dementia

Socially isolated older adults have a 27% higher chance of developing dementia, according to researchers from Johns Hopkins. The findings suggest that simple interventions could be meaningful.

For years, photographer Lori Grinker struggled to get along with her mother. When Lori moved into her mom's Aventura apartment to help with her mom's failing health (and continue chronicling her life), old wounds melted away.

An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.

Perkins in Winter Springs confirmed that it's the newest participant. Its back room will become a refuge for those diners every Tuesday afternoon.

The FDA overruled its own scientific advisers in approving Aduhelm, despite lack of proof that it met its promise of slowing patients' decline.

An analysis of 31 other studies concludes that, for people with hearing loss, hearing aids reduce their risk of long-term cognitive decline by 19%.

Sarasota's Roskamp Institute was the first to discover a protein that tends to form clumps in the brains of people with Alzheimer's. A new drug has been shown to reduce it.

The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.

In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.

Researchers are launching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease.